Inventor · disambiguated record
Richard J. Armitage
Also filed as: ARMITAGE RICHARD · ARMITAGE RICHARD J · ARMITAGE RICHARD JEFFREY
40 granted patents·8 pending applications·1,572 citations·filing 1990–2024
98Inventor score
Top patents by PatentIndex Score
48 records- 0197US5480981ACD30 ligandIMMUNEX CORP·Filed 1994·Granted Jan 2, 1996·259 cites·20 claims
- 0296US9243058B2BCMA antigen binding proteinsAMGEN INC·Filed 2013·Granted Jan 26, 2016·83 cites·26 claims
- 0396US6087329ACD40 ligand polypeptideIMMUNEX CORP·Filed 1998·Granted Jul 11, 2000·122 cites·8 claims
- 0495US7807796B2ULBP antibodiesIMMUNEX CORP·Filed 2008·Granted Oct 5, 2010·19 cites·9 claims
- 0594US10220090B2BCMA Antigen binding proteinsAMGEN INC·Filed 2015·Granted Mar 5, 2019·15 cites·17 claims
- 0694US7427669B2ULBP antibodiesIMMUNEX CORP·Filed 2006·Granted Sep 23, 2008·19 cites·18 claims
- 0794US5962406ARecombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the sameIMMUNEX CORP·Filed 1995·Granted Oct 5, 1999·96 cites·71 claims
- 0893US6653447B1ULBP DNA and polypeptidesIMMUNEX CORP·Filed 2000·Granted Nov 25, 2003·25 cites·32 claims
- 0993US6264951B1Methods of inhibiting CD40L binding to CD40 with soluble monomeric CD40LIMMUNEX CORP·Filed 1996·Granted Jul 24, 2001·86 cites·2 claims
- 1093US5674492AMethod of preventing or treating disease characterized by neoplastic cells expressing CD40IMMUNEX CORP·Filed 1994·Granted Oct 7, 1997·126 cites·18 claims
- 1192US8679487B2Anti-interleukin-4 receptor antibodiesARMITAGE RICHARD J·Filed 2010·Granted Mar 25, 2014·35 cites·17 claims
- 1292US7405270B2CD40-Ligand lacking native-pattern glycosylationIMMUNEX CORP·Filed 2002·Granted Jul 29, 2008·32 cites·27 claims
- 1391US6410711B1DNA encoding CD40 ligand, a cytokine that binds CD40IMMUNEX CORP·Filed 1999·Granted Jun 25, 2002·64 cites·68 claims
- 1491US5961974AMonoclonal antibodies to CD40 ligand, pharmaceutical composition comprising the same and hybridomas producing the sameIMMUNEX CORP·Filed 1994·Granted Oct 5, 1999·78 cites·8 claims
- 1590US5573924ACD27 ligandIMMUNEX CORP·Filed 1993·Granted Nov 12, 1996·82 cites·12 claims
- 1689US7193058B2ULBP antibodiesIMMUNEX CORP·Filed 2004·Granted Mar 20, 2007·21 cites·10 claims
- 1789US6458350B1ULBP DNA and polypeptidesIMMUNEX CORP·Filed 2000·Granted Oct 1, 2002·18 cites·12 claims
- 1889US5565321ADetection of mutations in a CD40 ligand geneIMMUNEX CORP·Filed 1994·Granted Oct 15, 1996·56 cites·12 claims
- 1988US5981724ADNA encoding CD40 ligand, a cytokine that binds CD40IMMUNEX CORP·Filed 1995·Granted Nov 9, 1999·65 cites·188 claims
- 2088US5801227AAntibodies to CD40Filed 1995·Granted Sep 1, 1998·99 cites·6 claims
- 2185US9926373B2Human CD30 ligand antigen binding proteinsNOVO NORDISK AS·Filed 2013·Granted Mar 27, 2018·10 cites·6 claims
- 2284US10465009B2BCMA antigen binding proteinsAMGEN INC·Filed 2013·Granted Nov 5, 2019·9 cites·23 claims
- 2383US6667039B1CD30 ligandIMMUNEX CORP·Filed 2000·Granted Dec 23, 2003·5 cites·32 claims
- 2483US5677430AAntibodies directed against CD30 ligandIMMUNEX CORP·Filed 1995·Granted Oct 14, 1997·28 cites·6 claims
- 2583US2025289898A1Human cd30 ligand antigen binding proteinsNOVO NORDISK AS·Filed 2024·Application pending·0 cites
- 2681US9587026B2Anti-interleukin-4 receptor antibodiesIMMUNEX CORP·Filed 2014·Granted Mar 7, 2017·3 cites·18 claims
- 2780US6290972B1Method of augmenting a vaccine response by administering CD40 ligandIMMUNEX CORP·Filed 1996·Granted Sep 18, 2001·26 cites·21 claims
- 2879US6143869ACD30 ligand oligomers and polypeptidesIMMUNEX CORP·Filed 1998·Granted Nov 7, 2000·21 cites·8 claims
- 2973US6391637B1Use of CD40 ligand, a cytokine that binds CD40, to stimulate hybridoma cellsFiled 1996·Granted May 21, 2002·17 cites·35 claims
- 3070US2022112295A1Human cd30 ligand antigen binding proteinsAMGEN INC·Filed 2021·Application pending·0 cites
- 3168US7232660B2CD30 ligandIMMUNEX CORP·Filed 2003·Granted Jun 19, 2007·0 cites·13 claims
- 3266US2009264349A1CD30 LigandIMMUNEX CORP·Filed 2007·Application pending·0 cites
- 3366US2019023798A1Use of interleukin-4 antagonists and compositions thereofIMMUNEX CORP·Filed 2018·Application pending·0 cites
- 3464US2018171016A1Use of interleukin-4 antagonists and compositions thereofIMMUNEX CORP·Filed 2018·Application pending·0 cites
- 3563US6106832ATreatment of individuals exhibiting defective CD40LIMMUNEX CORP·Filed 1996·Granted Aug 22, 2000·12 cites·8 claims
- 3661US2017137526A1Use of interleukin-4 antagonists and compositions thereofIMMUNEX CORP·Filed 2017·Application pending·0 cites
- 3758US8410252B2ULBP2 polypeptidesCOSMAN DAVID J·Filed 2010·Granted Apr 2, 2013·0 cites·13 claims
- 3856US6774224B2ULBP DNA and polypeptidesIMMUNEX CORP·Filed 2002·Granted Aug 10, 2004·0 cites·34 claims
- 3956US5753203ACD30 ligand conjugatesIMMUNEX CORP·Filed 1995·Granted May 19, 1998·5 cites·16 claims
- 4054US2018298105A1Human CD30 Ligand Antigen Binding ProteinsNOVO NORDISK AS·Filed 2018·Application pending·0 cites
- 4152US5726286AIsolated epstein-barr virus BZLF2 proteins that bind MHC class II beta chainsIMMUNEX CORP·Filed 1995·Granted Mar 10, 1998·13 cites·2 claims
- 4250US6613320B1Defective CD4+T-cells that express active CD40-LIMMUNEX CORP·Filed 2000·Granted Sep 2, 2003·0 cites·1 claims
- 4350US5925734AIsolated Epstein-Barr virus BZLF2 proteins that bind MHC class II βchainsIMMUNEX CORP·Filed 1997·Granted Jul 20, 1999·5 cites·6 claims
- 4446US5716623AIsolated Herpesvirus saimiri proteins that bind MHC Class II moleculesIMMUNEX CORP·Filed 1995·Granted Feb 10, 1998·11 cites·10 claims
- 4539US7309489B1Mouse CD40 ligand-specific antibodies and hybridomasIMMUNEX CORP·Filed 1999·Granted Dec 18, 2007·1 cites·3 claims
- 4637USD382176SMilk bag holderARMITAGE RICHARD·Filed 1995·Granted Aug 12, 1997·4 cites·1 claims
- 4736US5223605AInterleukin-4 binding protein-γIMMUNEX CORP·Filed 1990·Granted Jun 29, 1993·2 cites·4 claims
- 4834US2003091564A1Methods of treating an undesired immune response by blocking the binding 0f cd40 ligand to cd40Filed 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Richard J. Armitage files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →